A new Canadian guideline for managing opioid use disorders lays out the optimal
strategies for the treatment of opioid addiction, including recommending opioid agonist treatment with buprenorphine–naloxone as the preferred first-line treatment.

Guest: Dr. Evan Wood, Director of the BC Centre on Substance Use, and lead author of the new set of national guidelines.